I was contacted by a concerned investor, here's some reassurance.
I've been interested in the booming Cannabis industry within the US & Canada - It's only a matter of time before more countries start to realise the medicinal properties of this.
Previous Close 12.83
Open 12.93
Bid 13.08 x 1300
Ask 13.09 x 1400
Day's Range 12.80 - 13.17
52 Week Range 4.41 - 67.00
Volume 7,612,316
Avg. Volume 24,820,344
Market Cap 5.903B
EPS (TTM) -1.36
Earnings Date Nov 08, 2021 - Nov 12, 2021
1y Target Est 17.60+
Holders
4.68% of Shares Held by All Insider
12.48% of Shares Held by Institutions
13.09% of Float Held by Institutions
401 Number of Institutions Holding Shares
TLRY
TLRY
TLRY
TLRYUSD
2HQ
TLRY
2HQ
2HQ
2HQ
2HQ
2HQ
2HQ
2HQ
$FTX:TLRY0924
NDAQ
NAS100USD
$CURRENCYCOM:US100
I've been interested in the booming Cannabis industry within the US & Canada - It's only a matter of time before more countries start to realise the medicinal properties of this.
Previous Close 12.83
Open 12.93
Bid 13.08 x 1300
Ask 13.09 x 1400
Day's Range 12.80 - 13.17
52 Week Range 4.41 - 67.00
Volume 7,612,316
Avg. Volume 24,820,344
Market Cap 5.903B
EPS (TTM) -1.36
Earnings Date Nov 08, 2021 - Nov 12, 2021
1y Target Est 17.60+
Holders
4.68% of Shares Held by All Insider
12.48% of Shares Held by Institutions
13.09% of Float Held by Institutions
401 Number of Institutions Holding Shares
TLRYTLRYTLRYTLRYUSD2HQTLRY2HQ2HQ2HQ2HQ2HQ2HQ2HQ$FTX:TLRY0924
NDAQNAS100USD$CURRENCYCOM:US100
Note
Due to unexpected political and economic uncertainties we have a situation of mass sell off across all major indexes involved with the mess in Afghanistan.Note
Tilray remains bullish, With the CEO pledging to push legislations and encourage investors that progress will be made.Note
STRONG HOLDNote
Tilray Expansion - twitter.com/tilray/status/1432772711885914121Note
UPDATE = SHARE DILUTIONNote
the need for an increase in authorizedshares of common stock from 743,333,333 shares to 990,000,000 shares and the potential negative impacts to the Company
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.